Literature DB >> 2464938

Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.

K Ogomori1, T Kitamoto, J Tateishi, Y Sato, M Suetsugu, M Abe.   

Abstract

To clarify the distribution, morphology, and density of amyloid deposits in patients with Alzheimer's disease (AD), tissue sections from various areas of the central nervous system of 14 patients with AD and from 20 nondemented aged controls were investigated immunohistochemically using anti-beta protein antiserum. beta-protein amyloid deposits were present not only in the cores of the senile plaques and in the vascular wall (amyloid angiopathy), but also in various sized plaque-shaped fibrillary, perivascular, subpial, and subependymal deposits. Amyloid deposits were found mainly in the cerebral cortex in nondemented controls, while in AD they were distributed widely in the regions that were not affected in nondemented controls. The positivity of amyloid deposits in AD was 100% in the cerebral cortex, hippocampus, amygdala, thalamus, caudate nucleus, claustrum, hypothalamus, nucleus basalis of Meynert, and cerebellar cortex. Putamen and brain-stem nuclei were affected frequently, and the spinal cord, dentate nucleus, and globus pallidus were sometimes (less than 50%) affected. This result provides an evidence that Alzheimer's disease is a beta-protein amyloidosis of the central nervous system. An assessment of the distribution of amyloid deposits should prove to be useful for the histopathologic diagnosis of AD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464938      PMCID: PMC1879581     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  RECENT OBSERVATIONS ON SENILE CEREBRAL CHANGES AND THEIR PATHOGENESIS.

Authors:  P SCHWARTZ; J KURUCZ; A KURUCZ
Journal:  J Am Geriatr Soc       Date:  1964-10       Impact factor: 5.562

2.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

3.  Observations on the brains of non-demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1968 Sep-Oct       Impact factor: 3.181

4.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

5.  Glutaraldehyde, cyanuric chloride and tetrazotized O-dianisidine as coupling reagents in the passive hemagglutination test.

Authors:  S Avrameas; B Taudou; S Chuilon
Journal:  Immunochemistry       Date:  1969-01

6.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

7.  Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects.

Authors:  M Roth; B E Tomlinson; G Blessed
Journal:  Nature       Date:  1966-01-01       Impact factor: 49.962

8.  Presenile Alzheimer disease: amyloid plaques in the cerebellum.

Authors:  J D Pro; C H Smith; S M Sumi
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

9.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Juvenile Alzheimer's disease with myoclonus: amyloid plaques and grumose alteration in the cerebellum.

Authors:  H Ishino; S Higashi; M Chûta; H Ohta
Journal:  Clin Neuropathol       Date:  1984 Sep-Oct       Impact factor: 1.368

View more
  71 in total

1.  Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.

Authors:  T G Beach; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Electron microscopic study of paired helical filaments and cerebral amyloid using a novel en bloc silver staining method.

Authors:  E Reusche; K Ogomori; J Diebold; R Johannisson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques.

Authors:  A Probst; D Langui; S Ipsen; N Robakis; J Ulrich
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Alzheimer's disease affects limbic nuclei of the thalamus.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  A case of progressive supranuclear palsy with widespread senile plaques.

Authors:  S Sasaki; S Maruyama; C Toyoda
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

6.  In vivo characterization of the early states of the amyloid-beta network.

Authors:  Jorge Sepulcre; Mert R Sabuncu; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

7.  Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease.

Authors:  D M Mann; D Jones; P W South; J S Snowden; D Neary
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections.

Authors:  A Rosenwald; E Reusche; K Ogomori; H M Teichert
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 9.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 10.  Alzheimer's disease; taking the edge off with cannabinoids?

Authors:  V A Campbell; A Gowran
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.